Perspectives on the development of imatinib and the future of cancer research

Nat Med. 2009 Oct;15(10):1149-52. doi: 10.1038/nm1009-1149.
No abstract available

Publication types

  • Biography
  • Historical Article
  • Portrait
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Awards and Prizes*
  • Benzamides
  • Clinical Trials as Topic
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Imatinib Mesylate
  • Neoplasms / drug therapy*
  • Piperazines / history*
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / history*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / history*
  • Pyrimidines / therapeutic use*
  • Research / trends*
  • United States

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate

Personal name as subject

  • Brian J Druker